Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1960 1
1964 1
1967 1
1969 2
1973 3
1974 1
1979 1
1982 2
1986 1
1988 1
1990 2
1992 2
1993 2
1994 2
1995 2
1996 1
1998 2
1999 2
2000 1
2002 1
2004 3
2005 1
2010 2
2012 3
2013 6
2014 8
2015 4
2016 3
2017 5
2018 2
2019 2
2020 6
2021 6
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Neurostimulation for Parkinson's disease with early motor complications.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group. Schuepbach WM, et al. Among authors: kistner a. N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158. N Engl J Med. 2013. PMID: 23406026 Free article. Clinical Trial.
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group. Schuepbach WMM, et al. Among authors: kistner a. Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Neurology. 2019. PMID: 30737338 Free PMC article. Clinical Trial.
Does low birthweight matter?
Kistner A. Kistner A. Acta Paediatr. 2020 Feb;109(2):228-230. doi: 10.1111/apa.15064. Epub 2019 Nov 19. Acta Paediatr. 2020. PMID: 31746022 Free PMC article. No abstract available.
Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease.
Cavallieri F, Fraix V, Bove F, Mulas D, Tondelli M, Castrioto A, Krack P, Meoni S, Schmitt E, Lhommée E, Bichon A, Pélissier P, Chevrier E, Kistner A, Seigneuret E, Chabardès S, Moro E. Cavallieri F, et al. Among authors: kistner a. Ann Neurol. 2021 Mar;89(3):587-597. doi: 10.1002/ana.25994. Epub 2021 Jan 9. Ann Neurol. 2021. PMID: 33349939
Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease.
Bove F, Mulas D, Cavallieri F, Castrioto A, Chabardès S, Meoni S, Schmitt E, Bichon A, Di Stasio E, Kistner A, Pélissier P, Chevrier E, Seigneuret E, Krack P, Fraix V, Moro E. Bove F, et al. Among authors: kistner a. Neurology. 2021 Jun 2:10.1212/WNL.0000000000012246. doi: 10.1212/WNL.0000000000012246. Online ahead of print. Neurology. 2021. PMID: 34078713
Parkinson's disease: no milk today?
Kistner A, Krack P. Kistner A, et al. Front Neurol. 2014 Sep 5;5:172. doi: 10.3389/fneur.2014.00172. eCollection 2014. Front Neurol. 2014. PMID: 25250013 Free PMC article. Review.
[Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
Thobois S, Ardouin C, Schmitt E, Lhommée E, Klinger H, Xie J, Lagrange C, Kistner A, Aya Kombo M, Fleury V, Poisson A, Fraix V, Broussolle E, Pollak P, Krack P. Thobois S, et al. Among authors: kistner a. Rev Neurol (Paris). 2010 Oct;166(10):816-21. doi: 10.1016/j.neurol.2010.07.006. Epub 2010 Aug 23. Rev Neurol (Paris). 2010. PMID: 20739041 Review. French.
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Thobois S, Lhommée E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V, Pelissier P, Chabardes S, Mertens P, Quesada JL, Bosson JL, Pollak P, Broussolle E, Krack P. Thobois S, et al. Among authors: kistner a. Brain. 2013 May;136(Pt 5):1568-77. doi: 10.1093/brain/awt067. Epub 2013 Mar 29. Brain. 2013. PMID: 23543483 Clinical Trial.
79 results